Zawamed sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-01-15
Share capital
100,000.00 PLN
Activity description

Zawamed is a company that conducts preclinical and clinical research, as well as training using in vitro models. They support clients in various industries, including cosmetics, feed, food, and pharmaceuticals, by assisting with funding acquisition, study design, execution, result interpretation, and report creation. Additionally, they provide services related to clinical trial cost settlements and patient compensation.

Registered address
ul. Marii Rodziewiczówny 9, 07-300 Ostrów Mazowiecka, Poland
Website
Email
Phone
Social media
Electronic delivery address
AE:PL-15286-75439-ICARB-21

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 647 days for 2021), 1 not filed.

  • 2025not filed
  • 202422/07/2025
  • 2023not filed
  • 202222/04/2024
  • 202122/04/2024
  • 202029/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Scientific research and development1,106 / 1,943
Top 57%
Voivodeship · Mazowieckie95,840 / 142,215
Top 67%
Country · Poland344,254 / 496,512
Top 69%

Results vs industry

Revenue
This companyUSD 43.91kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -1.56kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 33.63kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 81.71kMedianUSD 134.71kAverageUSD 3.04m

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2021. In 2022 it is performing 1 contract worth USD 20.41. All its contracts were worth USD 20.41 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2022
Podstawowa Opieka Zdrowotnamazowieckie1USD 20.41

Authorized Representatives

Wioletta Krakówka age 49 – Vice President of the Management Board
Piotr Roman Orłowski age 41 – President of the Management Board

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
50$13,506.2150%
50$13,506.2150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-06-24.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Globe Badania Kliniczne sp. z o.o.
Ti-Com sp. z o.o.
Pharmaxi Poland sp. z o.o.
ETG Network sp. z o.o.
HTA Registry sp. z o.o.
Medapp Clinical Research sp. z o.o.
Biostat Research and Development sp. z o.o.
Biomedical Centers sp. z o.o.
Orphinic Scientific S.A.
Biolabic sp. z o.o.

Change history

DateEvent
2024-02-14Address change
2024-02-14Share capital increase
2020-05-05Address change
2020-05-05PKD change
2019-01-15Entered in the register

FAQ

Last updated: 2026-04-10